The ILAE - Latin America region comprises South and Middle America and Mexico where Spanish and Portuguese are the main languages spoken. Within the framework and according to the strategic plan of the central ILAE, the goal of the ILAE-Latin America is to serve as a regional resource for current and emerging knowledge on epilepsy prevention, diagnosis, treatment, and research.
Current efforts of the ILAE-Latin America are focused on the development of national epilepsy programs and laws and telemedicine projects in the region. In the field of education, courses are being organized for the primary health level as well as specialized epilepsy care.
As the region is extremely heterogeneous, an effort is being made to provide equal learning opportunities for health professionals in rich and poor countries and areas. Guidelines and seminal scientific articles that are available only in English are being translated into Spanish and Portuguese to increase access to knowledge.
Despite the decrease in the disease burden from 1990 to 2016, epilepsy is still an important cause of disability and mortality. Standardised collection of data on epilepsy in population representative surveys will strengthen the estimates, particularly in countries for which we currently have no or sparse data...
18 February, 2019
Factors predicting cessation of status epilepticus in clinical practice – data from a prospective observational registry (SENSE)
In clinical practice, treatment guidelines were not followed in a substantial proportion of patients. This under‐dosing correlated with lack of cessation of SE. Our data suggest that sufficiently dosed benzodiazepines should be used as first treatment step.
4 February, 2019
Mark your calendar! International Epilepsy Day is a special event which promotes awareness of epilepsy in more than 120 countries each year. Every year on the second Monday of February people join together to celebrate and highlight the problems faced by people with epilepsy, their families and…
14 January, 2019
In previously seizure‐free patients, switching the manufacturer of antiepileptic medications was associated with a higher risk for seizure recurrence. Our retrospective approach does not allow us to determine whether other changes in medical care at the same time could contribute to the recurrence. However, it would be prudent to avoid switching the manufacturer of anticonvulsants in seizure‐free patients. Ann Neurol 2018;84:918–925
2 January, 2019
Con la denominación de Liga Argentina Contra la Epilepsia, Asociación Civil (LACE) se constituye el 25 de noviembre del año 1947 una entidad de carácter civil, la que fija su domicilio en la Ciudad de Buenos Aires. Son sus propósitos la difusión en el país de los conocimientos vinculados con la…
20 December, 2018
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community